Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$42.38 +0.20 (+0.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Other Accumulated Expenses (2011 - 2026)

Updated

Supernus Pharmaceuticals' Other Accumulated Expenses came in at $198.84 million for Q2 2026, up 9.9% from $180.92 million a year earlier and up 4.8% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Other Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals' Other Accumulated Expenses was $161.1 million, down 4.5% from FY2024.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
  • Going back by year, Other Accumulated Expenses was $168.71 million in FY2024 (+9.4%), $154.27 million in FY2023 (+1.7%), $151.67 million in FY2022 (+14.3%) and $132.72 million in FY2021 (+5.2%).
  • The Q2 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2011.
  • Year-over-year, Other Accumulated Expenses increased in seven of the last eight quarters, with growth averaging 5.6%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in Q3 2022 (growth of 20.0%), and the weakest in Q2 2022 (a decline of 16.0%).
  • Business Quant data shows SUPN's Other Accumulated Expenses at $189.72 million (Q1 2026), $161.1 million (Q4 2025) and $184.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Supernus Pharmaceuticals 2.47 Bn 1.12 Bn 185.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.84 Mn
Mar 31, 2026 189.72 Mn
Dec 31, 2025 161.10 Mn
Sep 30, 2025 184.46 Mn
Jun 30, 2025 180.92 Mn
Mar 31, 2025 170.13 Mn
Dec 31, 2024 168.71 Mn
Sep 30, 2024 169.12 Mn
Jun 30, 2024 175.12 Mn
Mar 31, 2024 167.23 Mn
Dec 31, 2023 154.27 Mn
Sep 30, 2023 162.47 Mn
Jun 30, 2023 148.83 Mn
Mar 31, 2023 147.85 Mn
Dec 31, 2022 151.67 Mn
Sep 30, 2022 158.47 Mn
Jun 30, 2022 145.76 Mn
Mar 31, 2022 140.18 Mn
Dec 31, 2021 132.72 Mn
Sep 30, 2021 132.05 Mn
API Access

Supernus Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SUPN&period=max&api_key=YOUR_API_KEY